ARTICLE | Clinical News
Gattex regulatory update
February 6, 2012 8:00 AM UTC
FDA accepted for review an NDA from NPS for Gattex teduglutide to treat short bowel syndrome (SBS). NPS, which requested Priority Review, said it expects FDA to assign a PDUFA date this month. The com...